1 |
TGR ratio (post-TGR/pre-TGR)a
|
Target lesions only |
TTF <2 mo |
Tunali et al,22 2019 |
None |
Champiat et al,5 2017; Ferrara et al,6 2018; Aoki et al,10 2019; Kanjanapan et al,14 2019; Scheiner et al,202019; Ten Berge et al,21 2019; Matos et al,18 2020c; Kim et al,15 2019c; Arasanz et al,23 2020; Petrioli et al,25 2020 |
2 |
TGK ratio (post-TGK/pre-TGK)b
|
Target lesions only |
None |
Saâda-Bouzid et al,9 2017; Ji et al,12 2019; Lu et al,17 2019; Refae et al,26 2020 |
3 |
Early tumor burden increase |
Target lesions only |
TTF <2 mo |
Ruiz-Patiño et al,27 2020 |
None |
Abbas et al,28 2019; Forschner et al,24 2020 |
Target and new lesions |
TTF <2 mo |
Lo Russo et al,16 2019; Matos et al,18 2020c
|
4 |
Both TGK ratio and early tumor burden increase |
Target lesion only |
TTF <2 mo |
Kato et al,8 2017; Kamada et al,13 2019 |
None |
Sasaki et al,19 2019 |
Both TGR ratio and early tumor burden increase |
Target and new lesions |
TTF <2 mo |
Hwang et al,11 2020; Kim et al,15 2019c
|
Either TGR ratio or TGK ratio |
Target lesion only |
None |
Kim et al,7 2019 |